These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20470354)

  • 1. Can a microarray implicate human genes in post-transplant lymphoproliferative disorders?
    Davies M; Rowe D
    Pediatr Transplant; 2009 Dec; 13(8):944-7. PubMed ID: 20470354
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene expression using microarrays in transplant recipients at risk of EBV lymphoproliferation after organ transplantation: preliminary proof-of-concept.
    Allen U; Barton M; Beyene J; Hu P; Khodai-Booran N; Hébert D; Dipchand A; Ng V; Solomon M; Grant D; Fecteau A; Ngan B; Read S; Zielenska M; Weitzman S
    Pediatr Transplant; 2009 Dec; 13(8):990-8. PubMed ID: 19735433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics analysis in post-transplant lymphoproliferative disorders.
    Alsayed Y; Leleu X; Leontovich A; Oton AB; Melhem M; George D; Ghobrial IM
    Eur J Haematol; 2008 Oct; 81(4):298-303. PubMed ID: 18573174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
    Petrovic LM
    Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
    [No Abstract]   [Full Text] [Related]  

  • 5. Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients.
    Görzer I; Puchhammer-Stöckl E; van Esser JW; Niesters HG; Cornelissen JJ
    Clin Infect Dis; 2007 Mar; 44(5):693-5. PubMed ID: 17278061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
    Bar-Natan M; Nagler A
    Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
    Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR.
    Hamadani M; Martin LK; Benson DM; Copelan EA; Devine SM; Hofmeister CC
    Bone Marrow Transplant; 2007 Feb; 39(4):249-51. PubMed ID: 17290281
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus-associated lymphoproliferative disorders.
    Ambinder RF
    Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.
    Oudejans JJ; Jiwa M; van den Brule AJ; Grässer FA; Horstman A; Vos W; Kluin PM; van der Valk P; Walboomers JM; Meijer CJ
    Am J Pathol; 1995 Oct; 147(4):923-33. PubMed ID: 7573368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
    J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders.
    Rowe M; Niedobitek G; Young LS
    Springer Semin Immunopathol; 1998; 20(3-4):389-403. PubMed ID: 9870253
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation.
    Barshes NR; Lee TR; Goss JA; Goodpastor SE; Huls MH; Rooney CM; Karpen SJ; Wyllie S
    Transpl Infect Dis; 2006 Jun; 8(2):108-12. PubMed ID: 16734634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
    Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
    Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas.
    Rinaldi A; Kwee I; Poretti G; Mensah A; Pruneri G; Capello D; Rossi D; Zucca E; Ponzoni M; Catapano C; Tibiletti MG; Paulli M; Gaidano G; Bertoni F
    Br J Haematol; 2006 Jul; 134(1):27-36. PubMed ID: 16803564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
    Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
    Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
    Guinness ME; Kenney JL; Reiss M; Lacy J
    Cancer Res; 2000 Oct; 60(19):5354-8. PubMed ID: 11034070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.